INTRODUCTION
SESSION I: BASIC KNOWLEDGE FOR CV DEVICES DEVELOPMENT
SESSION II: TRANSLATIONAL PATHWAY FOR TRANSCATHETER AORTIC VALVE
SESSION III: TRANSLATIONAL PATHWAY FOR TRANSCATHETER MITRAL/TRICUSPID VALVE DEVICES
SESSION IV: TRANSLATIONAL PATHWAY FOR CORONARY STENT
SESSION V: TRANSLATIONAL PATHWAY FOR CATHETER ABLATION
SESSION VI: TRANSLATIONAL PATHWAY FOR VENTRICULAR ASSIST DEVICES
0% Complete
0/207 Steps

Translational Pathway to Expedite Scientific Discovery to Patients

Robert Califf, MD

Former Commissioner of Food and Drug Administration, FDA

Session Content
0% Complete 0/2 Steps